Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: The efficacy and safety of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients: a systematic review and meta-analysis

Fig. 7

Forest plots of risk ratios for grade ≥ 3 hematological and non-hematological toxicities during concurrent chemoradiotherapy. (a-d) Grade ≥ 3 hematological toxicities (leukopenia (a), neutropenia (b), thrombocytopenia (c), and anemia (d)) during concurrent chemoradiotherapy. (e-i) Grade ≥ 3 non-hematological toxicities (fatigue (e), nausea (f), vomiting (g), stomatitis (mucositis) (h), and dermatitis (i) during concurrent chemoradiotherapy

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us